Literature DB >> 12586351

Detection of bound and free IGF-1 and IGF-2 in human plasma via biomolecular interaction analysis mass spectrometry.

Dobrin Nedelkov1, Randall W Nelson, Urban A Kiernan, Eric E Niederkofler, Kemmons A Tubbs.   

Abstract

Insulin like growth factor (IGF)-1 and IGF-2 were assayed from human plasma via biomolecular interaction analysis mass spectrometry, utilizing antibodies as ligands for affinity retrieval. Detection of both targeted and non-targeted IGFs in the mass spectra indicated possible protein complex retrieval by the individual antibodies. A series of control experiments eliminated the possibility of analyte cross-walking between flow cells, significant antibodies cross-reactivity, and direct IGF interactions. To disrupt the putative protein complex and release its constituent proteins, plasma samples were treated with detergents. An SDS-treated plasma yielded IGF signals in a different ratio than the one observed in the mass spectra from the non-treated plasma, suggesting disruption of the protein complex, and its retrieval from non-treated plasma. Novel truncated IGF-2 variant, missing its N-terminal Alanine, was detected in all mass spectra.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586351     DOI: 10.1016/s0014-5793(03)00042-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Investigating diversity in human plasma proteins.

Authors:  Dobrin Nedelkov; Urban A Kiernan; Eric E Niederkofler; Kemmons A Tubbs; Randall W Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

Review 2.  Plasmon resonance methods in GPCR signaling and other membrane events.

Authors:  I D Alves; C K Park; V J Hruby
Journal:  Curr Protein Pept Sci       Date:  2005-08       Impact factor: 3.272

3.  Development of surface plasmon resonance mass spectrometry array platform.

Authors:  Dobrin Nedelkov
Journal:  Anal Chem       Date:  2007-06-23       Impact factor: 6.986

4.  Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.

Authors:  Paul E Oran; Olgica Trenchevska; Dobrin Nedelkov; Chad R Borges; Matthew R Schaab; Douglas S Rehder; Jason W Jarvis; Nisha D Sherma; Luhui Shen; Bryan Krastins; Dawn C Schwenke; Peter D Reaven; Randall W Nelson
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

Review 5.  Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Proteomes       Date:  2016-03-17

6.  Clinical utility of insulin-like growth factor 1 and 2; determination by high resolution mass spectrometry.

Authors:  Cory Bystrom; Shijun Sheng; Ke Zhang; Michael Caulfield; Nigel J Clarke; Richard Reitz
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.